Karin Rosen
Chief Tech/Sci/R&D Officer en HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY .
Perfil
En la actualidad, Karin Rosen ocupa el cargo de Directora Científica de Horizon Therapeutics Plc. En su anterior carrera, la Dra. Rosen ocupó el cargo de Vicepresidenta Senior de Asuntos Médicos de Estados Unidos en GlaxoSmithKline Plc. Se doctoró en la Universidad de Lund.
Cargos activos de Karin Rosen
Empresas | Cargo | Inicio |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Chief Tech/Sci/R&D Officer | 02/11/2020 |
DIAMYD MEDICAL AB | Director/Board Member | 10/03/2023 |
Antiguos cargos conocidos de Karin Rosen.
Empresas | Cargo | Fin |
---|---|---|
GSK PLC | Corporate Officer/Principal | 01/11/2020 |
Formación de Karin Rosen.
University of Lund | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GSK PLC | Health Technology |
DIAMYD MEDICAL AB | Health Technology |
Empresas privadas | 1 |
---|---|
Horizon Therapeutics Plc
Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |